• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Threadneedle Monthly Ex Income RDR Z Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Columbia Threadneedle
Fund Summary The aim of the Fund is to provide income with the potential to grow the amount you invested. The Fund invests at least two-thirds of its assets in shares in UK companies and in bonds (which are similar to a loan and pay a fixed or variable interest rate) issued in British Pounds. The Fund may also invest in asset classes and instruments different from those stated above.
SEDOL code B8BZ322
ISIN GB00B8BZ3226
Fund code THXIZ
Managers Richard Colwell, Alasdair Ross
Manager Tenure 9 years
Morningstar Category Currently unavailable
IMA Sector UK Equity And Bond Income
Fund Size £309 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.73%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £1.3972
Buy Price £1.3972
Price Change -0.3139%
Price Date 19th July 2019
Yield 3.93%
Dividend Frequency Monthly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 4th October 1999
Fund Status OPEN
Richard Colwell is a portfolio manager and Head of UK Equities at Columbia Threadneedle. He manages the Threadneedle UK Growth & Income Fund, Threadneedle UK Equity Income Fund and the Threadneedle UK Equity Alpha Income Fund. He also co-manages the Threadneedle Monthly Extra Income Fund and has research responsibility across all sectors. Before joining the company, Richard ran high alpha UK equity portfolios at Aviva Investors. He has also held portfolio management roles at Credit Suisse and Schroders and worked at the Bank of England. Richard has a degree in Banking, Insurance & Finance from the University of Bangor. He holds the Chartered Financial Analyst designation and is a member of the CFA Society of the UK as well as the Chartered Institute of Bankers.

3-year Mean Monthly Return: 0.605%

Annual Returns 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Fund Performance -0.22% +4.78% +17.54% +4.14% +6.60% +14.61% +22.52% +2.65% +21.82% +19.71%
Benchmark Performance
-1.72% +7.53% +17.76% +2.54% +4.78%
Time Period Cumulative Benchmark Performance
Fund Compared to Benchmark
1 day -0.31% -0.03% -0.29%
1 week 0.29% +1.54% -1.24%
1 month 1.88% +1.89% -0.02%
3 months 2.13% +3.85% -1.73%
6 months 7.68% +6.72% +0.96%
1 year 0.02% +1.01% -0.99%
3 years 20.41% +25.70% -5.28%
5 years 39.64% +35.01% +4.63%
10 years 187.30% +121.89% +65.41%
YTD 11.32% +9.60% +1.72%
Since inception 58.22% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 6.14%
GlaxoSmithKline PLC GBR 4.57%
Electrocomponents PLC GBR 3.29%
Phoenix Group Holdings PLC GBR 3.10%
Unilever PLC GBR 3.07%
Rentokil Initial PLC GBR 2.79%
Royal Dutch Shell PLC B GBR 2.79%
3i Ord GBR 2.76%
Morrison (Wm) Supermarkets PLC GBR 2.67%
RSA Insurance Group PLC GBR 2.61%
Dividend Date Per share amount Reinvestment Price
8th July 2019 0.0042 £1.3985
10th June 2019 0.0042 £1.3659
8th May 2019 0.0043 £1.3616
8th April 2019 0.0041 £1.3775
8th March 2019 0.0069 £1.3448
8th February 2019 0.0038 £1.3457